|
US3311628A
(en)
*
|
1965-03-09 |
1967-03-28 |
Bristol Myers Co |
Derivatives of pyrrolo [2, 3-d] pyrimidine
|
|
CH592668A5
(sr)
*
|
1973-10-02 |
1977-10-31 |
Delalande Sa |
|
|
ATE159257T1
(de)
*
|
1994-05-03 |
1997-11-15 |
Ciba Geigy Ag |
Pyrrolopyrimidinderivate mit antiproliferativer wirkung
|
|
US6686366B1
(en)
|
1998-06-02 |
2004-02-03 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
US6878716B1
(en)
|
1998-06-02 |
2005-04-12 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptor and uses thereof
|
|
EA003604B1
(ru)
*
|
1998-06-02 |
2003-06-26 |
Оси Фармасьютикалз, Инк. |
КОМПОЗИЦИИ НА ОСНОВЕ ПИРРОЛО [2,3d] ПИРИМИДИНОВ И ИХ ПРИМЕНЕНИЕ
|
|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
|
KR100415791B1
(ko)
*
|
1998-06-19 |
2004-01-24 |
화이자 프로덕츠 인코포레이티드 |
피롤로[2,3-디]피리미딘 화합물
|
|
US7160890B2
(en)
|
1999-12-02 |
2007-01-09 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
|
US6680322B2
(en)
|
1999-12-02 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
NZ518884A
(en)
|
1999-12-10 |
2004-02-27 |
Pfizer Prod Inc |
Pyrrolo[2,3-d]pyrimidine compounds
|
|
US6673802B2
(en)
|
2000-12-01 |
2004-01-06 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
US6680324B2
(en)
|
2000-12-01 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
DE10148883A1
(de)
*
|
2001-10-04 |
2003-04-10 |
Merck Patent Gmbh |
Pyrimidinderivate
|
|
DE60234118D1
(de)
|
2001-11-30 |
2009-12-03 |
Osi Pharm Inc |
Verbindungen, die für Adenosin A1 und A3 Rezeptoren spezifisch sind, und deren Anwendungen
|
|
CA2471059C
(en)
|
2001-12-20 |
2011-04-26 |
Osi Pharmaceuticals, Inc. |
Pyrimidine a2b selective antagonist compounds, their synthesis and use
|
|
CN1816551A
(zh)
|
2001-12-20 |
2006-08-09 |
Osi药物公司 |
吡咯并嘧啶A2b选择性拮抗剂化合物,它们的合成及用途
|
|
MXPA05005576A
(es)
|
2002-11-26 |
2005-07-27 |
Pfizer Prod Inc |
Procedimiento de tratamiento del rechazo a un trasplante.
|
|
JP2009523812A
(ja)
*
|
2006-01-19 |
2009-06-25 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
融合へテロ二環式キナーゼ阻害剤
|
|
CN102131812B
(zh)
|
2008-08-20 |
2014-04-09 |
硕腾有限责任公司 |
吡咯并[2，3-d]嘧啶化合物
|
|
NL2022471B1
(en)
|
2019-01-29 |
2020-08-18 |
Vationpharma B V |
Solid state forms of oclacitinib
|